Topical Ruxolitinib Therapeutic Cheat Sheet
RuxolitinibRuxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …
Ruxolitinib
Benefits and Risks of Medium & Deep Chemical Peels
chemical peelsNext Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium (PDE) interviewed Dr. Jennifer Rullan, a dermatologist in Chula Vista, Calif. Watch as Dr. Rullan outlines unexpected ingredients that dermatologists can use in medium depth and deep chemical peels to treat pigmentary disorders, and it may not be the disorders that you expect. Vitiligo? Idiopathic guttate hypomelanosis …
chemical peels
Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab
Dissecting CellulitisPerifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by multinodular lesions with purulent drainage and sinus tract formation. It is classically seen in middle-aged males of African descent. The etiology of the disease is unknown; however, leading theories …
Dissecting Cellulitis
What Dermatopathologists Wish Every Derm Knew About Nail Biopsies
Nail biopsiesNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed to Dr. Molly Hinshaw, professor of dermatology, section chief of dermatopathology and director of the nail clinic at the University of Wisconsin School of Medicine and Public Health. Watch as Dr. Hinshaw shares her tips for performing nail biopsies. Find out what’s the safest and most usef …
Nail biopsies
Medicolegal Implications of Regenerative Medicine and PRP
PRPNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Watch and find out why the FDA and Department of Justice are giving more attention to regenerative medicine in recent years. Learn how the FDA views platelet-ri …
PRP